Cancer / Immunology
Hummingbird Bioscience collaborates with Merck for a clinical trial on HMBD-002, our anti-VISTA antibody, in combination with KEYTRUDA®
Under this collaboration, Hummingbird will evaluate the safety, tolerability, and anti-tumor activity of its novel anti-VISTA antibody, HMBD-002, i...
October 26, 2021 | News
Rakuten,Karkinos Healthcare Announce Partnership to Expand Novel Cancer Care in India
Rakuten Medical is focused on developing and commercializing innovative cancer treatments for multiple indications based on its Illuminox™ platform. ...
October 25, 2021 | News
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody
The Australian grant represents PMC-309's third global patent approval since it received grants from Russia in June 2021 and South...
October 20, 2021 | News
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
News Facts: - Aichi Cancer Center and Fujitsu jointly developed new AI solution to support physicians in efficiently choosing medical treatment expected t...
October 19, 2021 | News
Hummingbird Bioscience to Present Pre-Clinical Data on Novel Biomarkers for HER3-driven Cancers
Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announce...
October 08, 2021 | News
Japan to Encourages Breakthrough Cancer Research
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company, today announced the two winners of the 17th annual JCA Mauvernay Awar...
October 05, 2021 | News
GenScript ProBio and AskGene Enter into a Non-exclusive License of A sdAb Targeting Immune Checkpoint Target
GenScript ProBio grants a non-exclusive global license to AskGene to use GenScript ProBio's sdAb targeting immune checkpoint target for disc...
September 27, 2021 | News
Australia Approved New Therapy to Treat Advanced Small Cell Lung Cancer
Highlights: ZEPZELCA® (lurbinectedin) is the first new therapy approved to treat second-line metastatic SCLC in Australia in more tha...
September 15, 2021 | News
Taiwan to provide smart access to personalized cancer care
Varian, a Siemens Healthineers company, announced today that China Medical University Hospital in Central Taiwan treated its first patient with E...
September 13, 2021 | News
Elekta to address Indonesia's cancer care gap with direct presence
Elekta (EKTA-B.ST) announced today that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address t...
August 25, 2021 | News
InnoCare Announces First Subject Dosed in Clinical Trial of ICP-332
InnoCare discovered and developed the oral drug candidate ICP-332. As a non-receptor tyrosine kinase, TYK2 is a member of the JAK kinase family, which is a...
August 16, 2021 | News
Terumo Blood and Cell Technologies and PhotonPharma Inc. announce collaboration to develop a novel cancer immunotherapy
Terumo Blood and Cell Technologies (Terumo), a medical device company specializing in a portfolio of technology, software and services for blood...
August 12, 2021 | News
VERAXA Biotech and Indivumed Cooperate on the Development of Precision Oncology Antibody
The targets have been identified by Indivumed’s discovery solution platform nRavel®, only two months after its launch. The antibody development a...
August 10, 2021 | News
Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model
Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...
August 06, 2021 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
